MedPath

Energy Expenditure in Chronic Kidney Disease

Completed
Conditions
Kidney Diseases
Chronic Kidney Diseases
Interventions
Other: Doubly-labelled water technique
Other: Resting Energy Expenditure
Registration Number
NCT03358966
Lead Sponsor
East and North Hertfordshire NHS Trust
Brief Summary

Patients with kidney disease need accurate advice on their diet. Researchers know very little about energy needs and nutritional requirements in kidney patients. Simple tools are needed to calculate calorie requirements so that good bed-side advice can be given to patients, and to allow cost-effective research. This study aimed to measur energy requirements in kidney disease using a gold-standard safe and very accurate method called the "doubly labelled water technique". The study has compared measurements with less costly measurements obtained using a device which measures oxygen content of air breathed out. The study has also measured physical activity levels with questionnaires.

Detailed Description

Background The function of the kidneys is to remove waste products of metabolism, and despite advances in treatment of CKD little is known about metabolic rate in renal disease. Increased knowledge about metabolic rate would have numerous potential benefits.

Little is known of the effects of metabolic rate on kidney disease. This study was designed to define the relationship of metabolic rate with degree of kidney function.

Study design and methods In an observational cohort study, the investigators studied Total Energy Expenditure in 80 patients with CKD stage 1-5 using the doubly-labelled water technique over a 14 day period. The group was divided such that half had stage 1-3 CKD and half stage 4-5. All subjects performed a comprehensive metabolic analysis including measurement of Resting Energy Expenditure using indirect calorimetry, bioimpedance, and body size measures. Physical activity was assessed using a Stanford 7 day recall questionnaire.

Data Analysis The data analysed will include determining the relationship between level of kidney disease as measured by eGFR and energy expenditure measured as Resting Energy Expenditure and doubly-labelled water Total Energy Expenditure. This will be determined by regression analysis. Additionally, comparison will be made between subjects with early-moderate (CKD stage 1-3) and advanced (CKD stage 4-5) CKD.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  1. CKD stages 1-5 according to the MDRD equation eGFR
  2. Age >18
Exclusion Criteria
  1. Abnormal thyroid stimulating hormone level or previous thyroid disorder
  2. Active malignancy
  3. Pregnancy
  4. Intercurrent illness or infection
  5. Hospital admission in month prior to enrolment
  6. Surgery in 4 weeks prior to enrolment
  7. HIV, Hepatitis B, Hepatitis C positive status
  8. Tuberculosis in the 12 months prior to enrolment.
  9. Active vasculitis or connective tissue disorder
  10. Organ transplantation.
  11. Treatment with immunosuppression, except low dose corticosteroids (<10mg/day prednisolone).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Early to moderate CKD (stage 1-3)Resting Energy Expenditure40 patients with CKD stage 1-3. All subjects performed a comprehensive metabolic analysis including measurement of Resting Energy Expenditure using indirect calorimetry, bioimpedance, doubly-labelled water technique and body size measures. Physical activity was assessed using a Stanford 7 day recall questionnaire.
Advanced CKD (stage 4-5)Doubly-labelled water technique40 patients with CKD stage 4-5. All subjects performed a comprehensive metabolic analysis including measurement of Resting Energy Expenditure using indirect calorimetry, bioimpedance, doubly-labelled water technique and body size measures. Physical activity was assessed using a Stanford 7 day recall questionnaire.
Advanced CKD (stage 4-5)Resting Energy Expenditure40 patients with CKD stage 4-5. All subjects performed a comprehensive metabolic analysis including measurement of Resting Energy Expenditure using indirect calorimetry, bioimpedance, doubly-labelled water technique and body size measures. Physical activity was assessed using a Stanford 7 day recall questionnaire.
Early to moderate CKD (stage 1-3)Doubly-labelled water technique40 patients with CKD stage 1-3. All subjects performed a comprehensive metabolic analysis including measurement of Resting Energy Expenditure using indirect calorimetry, bioimpedance, doubly-labelled water technique and body size measures. Physical activity was assessed using a Stanford 7 day recall questionnaire.
Primary Outcome Measures
NameTimeMethod
Energy expenditure using doubly labelled water14 days
Secondary Outcome Measures
NameTimeMethod
Resting Energy Expenditure using indirect calorimetry1 day
Whole body bioimpedance1 day
Stanford 7 day recall questionnaire physical activity level7 days
© Copyright 2025. All Rights Reserved by MedPath